Longevity Technology(@LongevityTech):AbbVie’s JUVMO (tavapadon) targets dopamine differently from older drugs and is expected in US pharmacies this month, the company says. https://t.co/GcvpgSJ3OY #longevity #AbbVie #JUVMO #tavapadon #dopamine

Longevity Technology

@LongevityTech

Daily news and insights on research, investments and technologies that extend life and improve the quality of that extended life. #Longevity#

Joined December 2018

2.3K Following 19K Followers

Longevity Technology@LongevityTech

2026.10.07 13:14

AbbVie’s JUVMO (tavapadon) targets dopamine differently from older drugs and is expected in US pharmacies this month, the company says. #longevity# #AbbVie# #JUVMO# #tavapadon# #dopamine#

Forward to community

Most Popular Users

1M Followers

957.3K Followers

1.1M Followers

6.3M Followers

578.9K Followers

347.1K Followers

1.2M Followers

504.5K Followers

The Wall Street Journal

22.3M Followers

2.8M Followers

672.5K Followers

2.7M Followers

241M Followers

4.3M Followers

26.4M Followers